Printed From BioPortfolio.com
Neurocognitive Outcomes in Primary CNS Lymphoma: Clinical Implications
12:35 EDT 13 Oct 2017 | Neurology Times
Primary central nervous system lymphoma (PCNSL) is a rare but aggressive malignancy that accounts for approximately 3% of all primary CNS cancer. New studies have changed the landscape of PCNSL treatment paradigms and expectations for outcome.
Original Article: Neurocognitive Outcomes in Primary CNS Lymphoma: Clinical Implications
